Why Buy Stock In TRxADE HEALTH Inc. (MEDS)?
TRxADE HEALTH Inc. (NASDAQ:MEDS) has a beta value of 1.15 and has seen 4.26 million shares traded in the last trading session. The company, currently valued at $54.20M, closed the last trade at $5.35 per share which meant it lost -$1.32 on the day or -19.79% during that session. The MEDS stock price is -102.24% off its 52-week high price of $10.82 and 42.06% above the 52-week low of $3.10. If we look at the companys 10-day average daily trading volume, we find that it stood at 33.3 million shares traded. The 3-month trading volume is 3.12 million shares. The consensus among analysts is that TRxADE HEALTH Inc. (MEDS) is a Buy stock at the moment, with a recommendation rating of 1.70. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.09. TRxADE HEALTH Inc. (NASDAQ:MEDS) trade information  Sporting -19.79% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 06/11/21 when the MEDS stock price touched $5.35 or saw a rise of 50.55%. Year-to-date, TRxADE HEALTH Inc. shares have moved 1.13%, while the 5-day performance has seen it change 40.05%. Over the past 30 days, the shares of TRxADE HEALTH Inc. (NASDAQ:MEDS) have changed 69.30%. Short interest in the company has seen 3830.0 shares shorted with days to cover at 0.06. Wall Street analysts have a consensus price target for the stock at $9.25, which means that the shares value could jump 42.16% from current levels. The projected low price target is $7.25 while the price target rests at a high of $11.00. In that case, then, we find that the current price level is -105.61% off the targeted high while a plunge would see the stock gain -35.51% from current levels. TRxADE HEALTH Inc. (MEDS) estimates and forecasts  The companys shares have lost -2.73% over the past 6 months, compared to 16.30% for the industry. Revenue growth from the last financial year stood is estimated to be -39.10%. 3 analysts offering their estimates for the company have set an average revenue estimate of $2.27 million for the current quarter. 3 have an estimated revenue figure of $2.49 million for the next quarter concluding in Sep 2021. Year-ago sales stood $6.59 million and $6.33 million respectively for this quarter and the next, and analysts expect sales will shrink by -65.60% for the current quarter and -60.70% for the next. If we evaluate the companys growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -46.30% over the past 5 years. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Add them to your watchlist before they take off! Get the Top 5 Stocks Now! Sponsored  MEDS Dividends  TRxADE HEALTH Inc. is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the companys debt issue. TRxADE HEALTH Inc. (NASDAQ:MEDS)s Major holders  Insiders own 59.46% of the company shares, while shares held by institutions stand at 13.79% with a share float percentage of 34.01%. Investors are also buoyed by the number of investors in a company, with TRxADE HEALTH Inc. having a total of 17 institutions that hold shares in the company. The top two institutional holders are National Asset Management, Inc. with over 0.28 million shares worth more than $1.44 million. As of Mar 30, 2021, National Asset Management, Inc. held 3.41% of shares outstanding. The other major institutional holder is Heartland Advisors Inc., with the holding of over 0.25 million shares as of Mar 30, 2021. The firms total holdings are worth over $1.31 million and represent 3.08% of shares outstanding. Also the top two Mutual Funds that are holding companys shares are Heartland Value Fund and Perritt Microcap Opportunities Fund. As of Mar 30, 2021, the former fund manager holds about 3.08% shares in the company for having 0.25 million shares of worth $1.31 million while later fund manager owns 89981.0 shares of worth $0.47 million as of Mar 30, 2021, which makes it owner of about 1.11% of companys outstanding stock.